Elevated neutrophil-to-hemoglobin ratio as an indicator of poor survival in hepatitis B virus-related decompensated cirrhosis

References

• Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–1761. doi:10.1016/S0140-6736(14)60121-5
   PubMed Web of Science ®Google Scholar
• Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001;34:46–52. doi:10.1016/s0168-8278(00)00011-8
   PubMed Web of Science ®Google Scholar
• Behroozian R, Bayazidchi M, Rasooli J. Systemic inflammatory response syndrome and MELD score in hospital outcome of patients with liver cirrhosis. Middle East J Dig Dis. 2012;4:168–172.
   PubMedGoogle Scholar
• Abdel-Khalek EE, El-Fakhry A, Helaly M, et al. Systemic inflammatory response syndrome in patients with liver cirrhosis. Arab J Gastroenterol. 2011;12:173–177. doi:10.1016/j.ajg.2011.11.006
   PubMedGoogle Scholar
• Rice J, Dodge JL, Bambha KM, et al. Neutrophil-to-lymphocyte ratio associates independently with mortality in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol. 2018;16:1786–1791.e1. doi:10.1016/j.cgh.2018.04.045
   PubMed Web of Science ®Google Scholar
• Weiss E, de la Grange P, Defaye M, et al. Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF. Front Immunol. 2020;11:619039. doi:10.3389/fimmu.2020.619039
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Comin-Colet J, De Francisco A, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. AmJ Hematol. 2017;92:1068–1078. doi:10.1002/ajh.24820
   PubMed Web of Science ®Google Scholar
• Wouters H, Van Der Klauw MM, De Witte T, et al. Association of anemia with health related quality of life and survival: a large population-based cohort study. Haematologica. 2019;104:468–476. doi:10.3324/haematol.2018.195552
   PubMed Web of Science ®Google Scholar
• Weiss G, Schett G. Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol. 2013;9:205–215. doi:10.1038/nrrheum.2012.183
   PubMed Web of Science ®Google Scholar
• Kurz K, Lanser L, Seifert M, et al. Anemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Fail. 2020;7:1880–1890. doi:10.1002/ehf2.12755
   PubMed Web of Science ®Google Scholar
• Ozatli D, Koksal AS, Haznedaroglu IC, et al. Erythrocytes: anemias in chronic liver diseases. Hematology. 2000;5:69–76. doi:10.1080/10245332.2000.11746489
   PubMedGoogle Scholar
• Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. JGastroenterol. 2021;56:593–619. doi:10.1007/s00535-021-01788-x
   PubMed Web of Science ®Google Scholar
• Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851–858. doi:10.1053/jlts.2002.35927
   PubMed Web of Science ®Google Scholar
• Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
   PubMedGoogle Scholar
• Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802–810. doi:10.1002/hep.20405
   PubMed Web of Science ®Google Scholar
• Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. JHepatol. 2014;60:1151–1157. doi:10.1016/j.jhep.2014.02.026
   PubMed Web of Science ®Google Scholar
• Qi X. Peripheral blood lymphocyte-to-monocyte ratio predicts mortality in patients with HBV-related decompensated cirrhosis. Clin Lab. 2019;65:139–145. doi:10.7754/Clin.Lab.2018.180717
   Web of Science ®Google Scholar
• Zhang H, Sun Q, Mao W, et al. Neutrophil-to-lymphocyte ratio predicts early mortality in patients with HBV-related decompensated cirrhosis. Gastroenterol Res Pract. 2016;2016:4394650. doi:10.1155/2016/4394650
   PubMed Web of Science ®Google Scholar
• Ding P, He X. Red cell distribution width-to-lymphocyte ratio as a new prognostic predictor in HBV-associated decompensated cirrhosis. Clin Lab. 2022;68:2356–2362. doi:10.7754/Clin.Lab.2022.220229
   Web of Science ®Google Scholar
• Wu J, Zhang X, Zhang X, et al. Correlation between platelet-to-neutrophil ratio and mortality in patients with HBV-associated decompensated cirrhosis. Clin Lab. 2021;67:1454–1460. doi:10.7754/Clin.Lab.2020.201001
   Web of Science ®Google Scholar
• Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009;15:4653–4658. doi:10.3748/wjg.15.4653
   PubMed Web of Science ®Google Scholar
• Scheiner B, Semmler G, Maurer F, et al. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int. 2020;40:194–204. doi:10.1111/liv.14229
   PubMed Web of Science ®Google Scholar
• Shibamoto A, Namisaki T, Suzuki J, et al. Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis. Hepatol Res. 2023;53:713–722. doi:10.1111/hepr.13904
   PubMed Web of Science ®Google Scholar
• Bothou C, Ruschenbaum S, Kubesch A, et al. Anemia and systemic inflammation rather than arterial circulatory dysfunction predict decompensation of liver cirrhosis. J Clin Med. 2020;9:1263. doi:10.3390/jcm9051263
   PubMed Web of Science ®Google Scholar
• Wang S, Zhou Z, Xu C, et al. Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis. BMC Gastroenterol. 2023;23:1. doi:10.1186/s12876-022-02618-x
   PubMed Web of Science ®Google Scholar
• Bizid S, Yacoub H, Mohamed G, et al. Does anemia have a potential effect on type 2 hepatorenal syndrome? Can J Gastroenterol Hepatol. 2020;2020:1134744. doi:10.1155/2020/1134744
   PubMed Web of Science ®Google Scholar
• Ren H, Li H, Deng G, et al. Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis. Ann Hepatol. 2023;28:101147. doi:10.1016/j.aohep.2023.101147
   PubMed Web of Science ®Google Scholar
• Yang J, Yan B, Yang L, et al. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study. BMC Gastroenterol. 2018;18:161. doi:10.1186/s12876-018-0893-9
   PubMed Web of Science ®Google Scholar
• Cai M, Yang N, Lin S, et al. Anemia predicts poor outcomes in patients with HBV-related decompensated cirrhosis. Clin Lab. 2021;67:797–803. doi:10.7754/Clin.Lab.2020.200701
   Web of Science ®Google Scholar
• Mathurin SA, Agüero AP, Dascani NA, et al. Anemia en pacientes internados con cirrosis: prevalencia, significación clínica y factores predictivos [Anemia in hospitalized patients with cirrhosis: prevalence, clinical relevance and predictive factors]. Acta Gastroenterol Latinoam. 2009;39:103–111. Spanish.
   PubMedGoogle Scholar
• Qamar AA, Grace ND, Groszmann RJ, et al. Incidence, prevalence, and clinical significance of abnormal hematologic in-dices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689–695. doi:10.1016/j.cgh.2009.02.021
   PubMed Web of Science ®Google Scholar
• Kalaitzakis E, Josefsson A, Castedal M, et al. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis. Scand J Gastroenterol. 2013;48:577–584. doi:10.3109/00365521.2013.777468
   PubMed Web of Science ®Google Scholar
• Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. JHepatol. 2014;61:1038–1047. doi:10.1016/j.jhep.2014.06.012
   PubMed Web of Science ®Google Scholar
• O'Leary J, Reddy K, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367–2374. doi:10.1002/hep.29773
   PubMed Web of Science ®Google Scholar
• Liu K, Wang FS, Xu R. Neutrophils in liver diseases: pathogenesis and therapeutic targets. Cell Mol Immunol. 2021;18:38–44. doi:10.1038/s41423-020-00560-0
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–175. doi:10.1038/nri3399
   PubMed Web of Science ®Google Scholar
• Curi R, Levada-Pires AC, Silva EBD, et al. The critical role of cell metabolism for essential neutrophil functions. Cell Physiol Biochem. 2020;54:629–647. doi:10.33594/000000245
   PubMedGoogle Scholar